Hepatic steatosis and dietary triglyceride content induced in a model of obese-simple fatty liver are reduced by DGAT2 antisense oligonucleotides in a manner that does not correlate with changes in body weight, adiposity or insulin sensitivity [56]. The gene discussed is DGAT2; the disease is fatty liver disease.